Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
829.00    9.00 (1.10%)
Bid:
827.00
Ask:
833.00
Spread: 6.00 (0.726%)
Market Cap: £782.94m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

14 Jan 2016 07:00

RNS Number : 7852L
Polar Capital Holdings PLC
14 January 2016
 

14 January 2016

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

The table below sets out the movements in the Group's AUM over the nine month period. For the first time the AUM figures are shown in both US dollars as has historically been the practice and British pounds sterling the currency of the Group's financial statements.

 

Polar Capital reports that as at 31 December 2015 its AUM were $11.9bn (£8.1bn) compared to $12.3bn (£8.3bn) at the end of March 2015.

 

 

AUM movement in

nine months to

31 December 2015

USD

GBP

Long only

Funds

Alternative funds

Total

Long only

funds

Alternative funds

Total

AUM at

31 March 2015

$11,185m

$1,071m

$12,256m

£7,548m

£723m

£8,271m

Net subscriptions

/ (redemptions)

$(436)m

$67m

$(369)m

£(286)m

£44m

£(242)m

Market movement

and performance

$1m

$(13)m

$(12)m

£34m

£(4)m

£30m

Total AUM at

31 December 2015

$10,750m

$1,125m

$11,875m

£7,296m

£763m

£8,059m

 

Comment

 

Despite the challenging market conditions we were pleased to return to net inflows for the December quarter which totalled $341m (£218m). Our main Japan fund continued to see redemptions but at a much reduced level compared to previous quarters.

For the first time since 2008 our highly successful Forager fund did not contribute to the overall performance fee figure as it was marginally down for the year. The overall amount of performance fees earned in the year was therefore somewhat lower than we would have anticipated at the start of the year.

The short-term outlook for markets is highly uncertain although we remain optimistic on the outlook for growing our assets and profits over the longer term given the breadth of our product offering and the long term performance record across our funds. This can be evidenced by the fact that as shown below, 12 of our 17 Lipper rated open ended funds (those with at least a one year track record) are first or second quartile over one year, continuing the excellent record since inception.

 

 

1 year

3 Years

5 years

Since

inception

1st quartile

8 funds

5 funds

3 funds

11 funds

2nd quartile

4 funds

3 funds

2 funds

4 funds

3rd quartile

2 funds

3 funds

2 funds

2 funds

4th quartile

3 funds

1 fund

N/A

N/A

 

 

 

Net performance fees (unaudited)

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first nine months of the Group's financial year.

 

Performance fees

net of staff allocations

Nine months to

31 Dec 14

Year to

31 Mar 15

(year-end)

Nine months to

31 Dec 15

Received

£5.1m

£5.2m

£3.0m

Accrued but not yet earned in funds with year ends on or before the financial year end

£0.3m

-

-

Total net performance fees

£5.4m

£5.2m

£3.0m

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Kit Stephenson

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASFDFEAKEFF
Date   Source Headline
8th Jul 20217:00 amRNSAuM Update
1st Jul 202111:07 amRNSDividend Declaration
1st Jul 202110:26 amRNSDirector Declaration
1st Jul 20217:00 amRNSGroup Audited Results for year ended 31 March 2021
29th Jun 20213:53 pmRNSForm 8.3 - Ultra Electronics Holdings PLC
7th Jun 20217:00 amRNSNotice of Results
1st Jun 20217:00 amRNSTotal Voting Rights
26th May 20215:35 pmRNSDirector/PDMR Shareholding
21st May 20212:21 pmRNSDirector/PDMR Shareholding
20th May 202111:36 amRNSIssue of Equity
20th May 202110:38 amRNSHolding(s) in Company
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 202112:45 pmRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSIssue of Equity
16th Apr 20217:00 amRNSDirector/PDMR Shareholding
15th Apr 20217:00 amRNSAuM Update
13th Apr 20214:27 pmRNSHolding(s) in Company
1st Apr 202110:44 amRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
25th Mar 20215:45 pmRNSHolding(s) in Company
18th Mar 20214:08 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSCompletion of Dalton SP LLP Acquisition
26th Feb 20214:33 pmRNSDirector/PDMR Shareholding
26th Feb 20214:32 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSIssue of Equity
1st Feb 20215:35 pmRNSIssue of Equity
1st Feb 20217:00 amRNSBlock listing Interim Review
1st Feb 20217:00 amRNSTotal Voting Rights
25th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSIssue of Equity
20th Jan 20215:25 pmRNSDirector/PDMR Shareholding
20th Jan 20215:22 pmRNSIssue of Equity
19th Jan 20219:39 amRNSIssue of Equity
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSIssue of Equity
14th Jan 20217:00 amRNSAuM Update
17th Dec 20207:00 amRNSAcquisition of Dalton Strategic Partnership LLP
4th Dec 202010:08 amRNSIssue of Equity
1st Dec 20207:00 amRNSTotal Voting Rights
25th Nov 20203:36 pmRNSIssue of Equity
19th Nov 20207:00 amRNSUnaudited interim results
16th Nov 20202:13 pmRNSForm 8.3 - CPL RESOURCES PLC
2nd Nov 20208:51 amRNSTotal Voting Rights
23rd Oct 20204:26 pmRNSNotice of Results
19th Oct 20207:00 amRNSTeam Acquisition Completion
8th Oct 20204:48 pmRNSIssue of Equity
8th Oct 20207:00 amRNSAuM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.